← FDA DRUG APPROVALS

FDA ANDA · ANDA076062

ZOLPIDEM TARTRATE

Sponsor: STRIDES PHARMA

APPLICATION
ANDA076062
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-23
LATEST ACTION
2023-03-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ZOLPIDEM TARTRATEDiscontinued
ZOLPIDEM TARTRATE 10MG · TABLET · ORAL
ZOLPIDEM TARTRATEDiscontinued
ZOLPIDEM TARTRATE 5MG · TABLET · ORAL

Approval history

2023-03-07Labeling · Supplement 1 · standardAP
2023-03-07Labeling · Supplement 2 · standardAP
2007-04-23OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →